Anavex Life Sciences Corp.

AVXL

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001314052

SEC filings (opens in a new tab)

No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Anavex Life Sciences Corp. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of AVXL: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Of which not filed for Q3 2025	Q3 2025	Change
Holders	178	2	186	+10
Shares	32.5M	20.6K	32.8M	+350.3K (+1.1%)
Value	$301.9M	$189.6K	$289.3M	−$12.4M (−4.1%)

2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Anavex Life Sciences Corp. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to AVXL in Q3 2025
Institution	Shares	Value	% of portfolio
Sheets Smith Investment Management	135,948	$1.21M	0.78%
XTX Topco Ltd	81,702	$727.1K	0.04%
Gsa Capital Partners LLP	63,080	$561.0K	0.05%
MetLife Investment Management	44,605	$397.0K	0.00%
Mariner, LLC	26,356	$234.6K	0.00%
Twinbeech Capital LP	25,944	$230.9K	0.01%
Man Group plc	24,385	$217.0K	0.00%
Axq Capital, LP	19,101	$170.0K	0.07%
Brevan Howard Capital Management LP	17,224	$153.3K	0.00%
Janney Montgomery Scott LLC	16,164	$144.0K	0.00%
Virtu Financial LLC	12,859	$114.0K	0.01%
Engineers Gate Manager LP	10,956	$97.5K	0.00%
SG Americas Securities, LLC	10,940	$97.0K	0.00%
Rockefeller Capital Management L.P.	7,400	$65.9K	0.00%
Quarry LP	4,049	$36.0K	0.01%
Quest Partners LLC	3,229	$28.7K	0.00%
Quadrant Capital Group LLC	1,851	$16.5K	0.00%
Steward Partners Investment Advisory, LLC	1,819	$16.2K	0.00%
Wealthspire Advisors, LLC	1,500	$13.3K	0.00%
Advisory Services Network, LLC	1,200	$10.7K	0.00%
POM Investment Strategies, LLC	1,000	$8.90K	0.00%
Smartleaf Asset Management LLC	883	$7.64K	0.00%
Root Financial Partners, LLC	687	$6.11K	0.00%
American Wealth Advisors, LLC	424	$3.77K	0.00%
Atlantic Union Bankshares Corp	350	$3.12K	0.00%
SRS Capital Advisors, Inc.	213	$1.90K	0.00%
Optiver Holding B.V.	204	$1.82K	0.00%

Sold out (17)

Institutions that held Anavex Life Sciences Corp. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of AVXL in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Balyasny Asset Management LLC	245,624	$2.26M
Dimensional Fund Advisors LP	45,899	$423.2K
Stratos Wealth Partners, LTD.	26,600	$245.3K
Corton Capital Inc.	24,517	$226.0K
SeaCrest Wealth Management, LLC	19,700	$181.6K
ADAR1 Capital Management, LLC	16,221	$149.6K
American Century Companies Inc	14,667	$135.2K
Lido Advisors, LLC	12,100	$111.6K
Squarepoint Ops LLC	10,744	$99.1K
Berkshire Money Management, Inc.	10,000	$92.2K
CIBC Private Wealth Group, LLC	1,200	$11.1K
Glenmede Investment Management, LP	288	$2.65K
Federated Hermes, Inc.	130	$1.20K
Beacon Capital Management, LLC	110	$1.01K
Skopos Labs, Inc.	78	$720
Twin Peaks Wealth Advisors, LLC	1	$11
Bessemer Group Inc	1	$0

Not filed for Q3 2025 yet (2)

Institutions that held Anavex Life Sciences Corp. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AVXL in Q2 2025 that haven't filed for Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
CIBC World Markets Corp	10,300	$95.0K
E Fund Management Co., Ltd.	10,259	$94.6K